Company Data
Immunome Inc.
Ticker
IMNM
Current Price
$9.9 -0.5%
Market Cap
$861.7M
Price Target
Refer to Report
Volume
412.5K
52wk Range
$5.1501 - $16.73
Overview
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The company’s primary focus areas are oncology and infectious disease, including COVID-19.